FTL and pancreatic neoplasm: Another ferritin subunit type, FTL, exhibited low expression in KRAS-mutant cells but relatively high expression in the KRAS-WT pancreatic cancer cell line BxPC-3, indicating that variations in FTH1 and FTL expression may be key factors driving pancreatic cancer progression in patients with different KRAS mutation statuses.